Venetoclax+HMA+Aclarubicin Versus Venetoclax+HMA in Treatment-Naive Elderly Patients With AML

NCT05264883 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

170

Enrollment

OTHER

Sponsor class

Conditions

Acute Myeloid Leukemia

Interventions

DRUG: Venetoclax-Decitabine/Azacitidine-Aclarubicin Association
DRUG: Venetoclax-Decitabine/Azacitidine Association

Sponsor

The First Affiliated Hospital with Nanjing Medical University

Collaborators

[object Object]
[object Object]
[object Object]